Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV003226898 | SCV003924007 | pathogenic | not provided | 2023-05-04 | criteria provided, single submitter | clinical testing | Reported in 3 members of a family with porencephaly (Gould et al., 2005; Gasparini et al, 2016); also identified in an unrelated infant with intracerebral hemorrhages, brain atrophy and ventriculomegaly and in his father with minor white matter abnormalities (Vermeulen et al., 2011); Affects a glycine residue in a Gly-X-Y motif in the triple helical region of the COL4A1 gene, where the majority of pathogenic missense variants occur, and is predicted to disrupt normal protein folding and function (Weng et al., 2012; Yoneda et al., 2013); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 20166936, 17696175, 15905400, 15136694, 22914737, 33013618, 27794444, 30284656, 20818663, 26686511, 30413629, 21500141, 22522439, 23225343) |
OMIM | RCV002247362 | SCV000039243 | pathogenic | Brain small vessel disease 1 with or without ocular anomalies | 2005-05-20 | no assertion criteria provided | literature only | |
Gene |
RCV002247362 | SCV000055812 | not provided | Brain small vessel disease 1 with or without ocular anomalies | no assertion provided | literature only | ||
Biochemical Molecular Genetic Laboratory, |
RCV002247362 | SCV001469220 | pathogenic | Brain small vessel disease 1 with or without ocular anomalies | 2020-05-06 | no assertion criteria provided | clinical testing |